I am holding Geojit Financial shares at ₹65. What is the technical outlook for the stock?
Sanjay
Geojit Financial Services (₹84.5) : The stock of Geojit Financial Services was on a long-term downtrend after marking an all-time high at ₹147 in October 2017 until it recorded a multi-year low at ₹14.9 in March 2020. Subsequently, the stock formed a base in the band between ₹15 and ₹20 and reversed direction. Since March 2020, the stock has been in an intermediate-term uptrend, forming higher peaks and higher lows. This May the stock skyrocketed 28 per cent and conclusively breached a key long-term barrier at ₹60. Thereafter, it continued to trend upwards and last week it surpassed a key resistance at ₹80 by gaining 10 per cent. However, the stock now faces a vital long-term resistance ahead at ₹90.
![1107GeojitFinancialcolcol 1107GeojitFinancialcolcol](/theme/images/bl-online/1x1_spacer.png)
An emphatic break above this level will reinforce the bullish momentum and take the stock northwards to ₹100 and then to ₹110. Thereafter resistances are placed at ₹120 and ₹140. On the other hand, if the stock declines below ₹80 it can witness a corrective decline and test next support at ₹72. But a further fall below this level will alter the short-term uptrend and pull the stock down to ₹60.You can stay invested with a stop-loss at ₹77 and can consider booking partial profit at ₹100. Vital supports below ₹60 are placed at ₹50 and ₹45. A decisive fall below the significant base level of ₹40 will alter the uptrend and pull the stock down to ₹30 levels over the long run.
Can I buy shares of Morepen Laboratories and Suven Life Sciences at current price?
Sudhakar Reddy
Morepen Laboratories (₹70.9) : Last week, the stock of Morepen Laboratories jumped 12 per cent, breaking above a key hurdle at ₹65, and registered a new high at ₹75. If you are an investor with a high risk appetite and looking for short-term gains, consider buying the stock at current levels with a stop-loss at ₹62.
![1107MorepenLabcolcol 1107MorepenLabcolcol](/theme/images/bl-online/1x1_spacer.png)
The stock can continue the long-term uptrend that has been in place from the March 2020 low of ₹7.2. While trending up, the stock exceeded a key long-term barrier at ₹40 in April 2021 and continued to trend upwards. Since then, it has been in a medium-term uptrend. A rally above ₹75 can take the stock higher to ₹80 and then to ₹90 levels. Supports below ₹60 are placed at ₹55 and ₹50.
Suven Life Sciences (₹89.7) : The stock of Suven Life Sciences has been in a medium-term downtrend since it met with a key resistance at ₹110 in May 2021. It trades well below the 21- and 50-day moving averages. A fall below the current support level of ₹87 can pull it lower to ₹80 and then to ₹76. Key medium-term support below ₹76 is at ₹70. Resistances above ₹95 are placed at ₹100 and ₹110. You can wait and buy the stock at lower levels with a stop-loss at ₹67.
Send your queries to techtrail@thehindu.co.in
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.